Jane Street’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-64,916
| Closed | -$148K | – | 10648 |
|
|
2024
Q2 | $148K | Sell |
64,916
-268,656
| -81% | -$1.03M | ﹤0.01% | 8582 |
|
|
2024
Q1 | $1.44M | Buy |
333,572
+110,972
| +50% | +$387K | ﹤0.01% | 4732 |
|
|
2023
Q4 | $679K | Buy |
222,600
+212,205
| +2,041% | +$399K | ﹤0.01% | 6256 |
|
|
2023
Q3 | $15K | Buy |
+10,395
| New | +$20.1K | ﹤0.01% | 8341 |
|
|
2023
Q2 | – | Sell |
-56,040
| Closed | -$150K | – | 9780 |
|
|
2023
Q1 | $150K | Sell |
56,040
-76,084
| -58% | -$366K | ﹤0.01% | 8013 |
|
|
2022
Q4 | $717K | Buy |
132,124
+50,496
| +62% | +$423K | ﹤0.01% | 5539 |
|
|
2022
Q3 | $1.02M | Buy |
81,628
+58,383
| +251% | +$667K | ﹤0.01% | 5380 |
|
|
2022
Q2 | $115K | Sell |
23,245
-12,590
| -35% | -$69.7K | ﹤0.01% | 8559 |
|
|
2022
Q1 | $272K | Sell |
35,835
-14,222
| -28% | -$135K | ﹤0.01% | 8547 |
|
|
2021
Q4 | $511K | Sell |
50,057
-14,780
| -23% | -$188K | ﹤0.01% | 7233 |
|
|
2021
Q3 | $870K | Buy |
64,837
+25,186
| +64% | +$410K | ﹤0.01% | 6195 |
|
|
2021
Q2 | $870K | Sell |
39,651
-80,000
| -67% | -$1.78M | ﹤0.01% | 6125 |
|
|
2021
Q1 | $2.88M | Buy |
119,651
+93,056
| +350% | +$2.16M | ﹤0.01% | 3334 |
|
|
2020
Q4 | $478K | Buy |
26,595
+5,269
| +25% | +$78.7K | ﹤0.01% | 5814 |
|
|
2020
Q3 | $247K | Buy |
+21,326
| New | +$352K | ﹤0.01% | 6159 |
|
|
2019
Q4 | – | Sell |
-13,847
| Closed | -$315K | – | 5916 |
|
|
2019
Q3 | $315K | Buy |
+13,847
| New | +$436K | ﹤0.01% | 4121 |
|
|
2018
Q4 | – | Sell |
-14,312
| Closed | -$748K | – | 5895 |
|
|
2018
Q3 | $748K | Buy |
+14,312
| New | +$780K | ﹤0.01% | 3124 |
|
Jane Street's GTHX Position: Q3 2024 in Review
Jane Street sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 64,916 shares — an estimated $148K sold.
Jane Street first reported a position in GTHX in Q3 2018 and held it in 17 quarters. The position peaked at $2.88M in Q1 2021. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.
- Jane Street reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Jane Street sold 64,916 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $148K.
- Jane Street first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2018 and held it in 17 quarters.
- Jane Street's G1 Therapeutics, Inc. Common Stock position peaked at $2.88M in Q1 2021.
- 0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.
Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.